These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1654529)

  • 21. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
    González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
    Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit.
    Besso L; Rovere A; Peano G; Menardi G; Fenoglio LM; Fenoglio S; Ghezzi PM
    Nephron; 1992; 61(3):304-6. PubMed ID: 1323775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus in chronic hemodialysis patients with non-A, non-B hepatitis.
    Yoshida CF; Takahashi C; Gaspar AM; Schatzmayr HG; Ruzany F
    Nephron; 1992; 60(2):150-3. PubMed ID: 1313155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis G virus exposure in dialysis staff.
    Eslamifar A; Hamkar R; Ramezani A; Ahmadi F; Gachkar L; Jalilvand S; Adibi L; Khameneh A; Atabak S; Ghadimi R; Aghakhani A
    Ther Apher Dial; 2007 Oct; 11(5):370-4. PubMed ID: 17845396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
    Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
    Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-HCV antibodies among hemodialysed and kidney-transplanted patients].
    Juszczyk J; Flieger J; Syczewska M; Krzymański M
    Przegl Epidemiol; 1994; 48(1-2):3-9. PubMed ID: 8073139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus infection in renal dialysis patients in Glasgow.
    McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
    Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C antibody in renal transplant patients.
    Klauser R; Franz M; Traindl O; Pidlich J; Hay U; Watschinger B; Pohanka E; Kovarik J
    Transplant Proc; 1992 Feb; 24(1):286-8. PubMed ID: 1371619
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis C virus antibodies in dialysis pediatric patients.
    Di Loreto M; Ferrante M; Panaro A; Sorino P; Collela V; Caringella DA
    Nephron; 1992; 61(3):365-6. PubMed ID: 1323793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to hepatitis C virus in patients on haemodialysis.
    Alonso MC; Novoa D; Romero R; Arcocha V; Sanchez-Guisande D
    Nephron; 1991; 57(2):247. PubMed ID: 1850500
    [No Abstract]   [Full Text] [Related]  

  • 32. Further insights into hepatitis C.
    Colombo M
    Ital J Gastroenterol; 1991 Dec; 23(9):574-5. PubMed ID: 1662092
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.
    Ponz E; Campistol JM; Barrera JM; Gil C; Pinto J; Andreu J; Bruguera M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1371-2. PubMed ID: 1846466
    [No Abstract]   [Full Text] [Related]  

  • 34. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay.
    Mondelli MU; Cristina G; Piazza V; Cerino A; Villa G; Salvadeo A
    Nephron; 1992; 61(3):350-1. PubMed ID: 1323788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
    Chan TM; Lok AS; Cheng IK; Chan RT
    Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of antibody to hepatitis C virus in renal transplant recipients.
    Fernandez JA; Roth D; Burke G; Ranjan D; Esquenazi V; Miller J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):444-5. PubMed ID: 1846716
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Oncel M; Akbulut S; Toka Ozer T; Kiyici A; Keles M; Baltaci B; Turk S
    Ren Fail; 2016 Aug; 38(7):1071-5. PubMed ID: 27267129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Again on HCV prevalence and the different types of testing sera.
    Lombardi M; Dattolo P
    Nephrol Dial Transplant; 1993; 8(10):1181. PubMed ID: 8272237
    [No Abstract]   [Full Text] [Related]  

  • 40. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.